Special Report
Compounding pharmacists are concerned about Express Scripts' decision to stop covering around 1,000 active compounded drug ingredients used by compounding pharmacies to create topical treatments. Starting this week, Express Scripts is blocking coverage for the ingredients, citing rising costs.
|
Express Scripts said the amount spent by its clients for compounded drugs increased to roughly $171 million in this year’s first quarter, up from $28 million during the comparable period in 2012. |
Like
Tweet
